Japson Pharmaceuticals (Pb) Limited - Company Profile

It is a healthcare public limited company based in Manimajra, Chandigarh, India, established in 1983.
1983 Manimajra, Chandigarh, India Active
Last Updated:
Access Report
About Japson Pharmaceuticals (Pb) Limited

Japson Pharmaceuticals (Pb) Limited, a active public limited company, was established on 16 June 1983 in Manimajra, Chandigarh, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U56102CH1983PLC005474. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹6.50 M.

It upholds a compliant status. Its leadership includes Angad Barnala Pratap (Director), Abhay Barnala (Director), Pervesh Bir (Director). Past directors included Majeed Najimudeen, Angad Barnala Pratap, Abhay Barnala. It holds ₹7.25 M open charges and ₹3.49 Cr settled loans. Its latest AGM occurred on 22 July 2024, with the balance sheet filed on 31 March 2024. It is based at 6328, Ground Floor, Rajiv Vihar,, Manimajra, Chandigarh, 160101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U56102CH1983PLC005474

  • Registration Number

    005474

  • Incorporation Date

    16 June 1983

  • Authorized Capital

    ₹8.00 M

  • Paid-Up Capital

    ₹6.50 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.00 M
  • Paid Up Capital ₹ 6.50 M
  • Company Age 42 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 7.25 M
  • Satisfied Charges ₹ 3.49 Cr
Company report

Japson Pharmaceuticals (Pb) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Japson Pharmaceuticals (Pb) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Japson Pharmaceuticals (Pb) Limited?
Current Directors
Name Designation Appointment Date Status
Angad Barnala Pratap Director 03 May 2019 Current
Abhay Barnala Director 03 May 2019 Current
Pervesh Bir Director 15 Jan 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Apr 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 21 Jul 2024 Past
Pramod Abcsdd Nominee Director 28 May 2019 Past
Pramod Abcsdd Managing Director 15 Jan 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Japson Pharmaceuticals (Pb).
Japson Pharmaceuticals (Pb) revenue growth over time
Japson Pharmaceuticals (Pb) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Japson Pharmaceuticals (Pb)?

Unlock access to Japson Pharmaceuticals (Pb)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,250,000.00

Satisfied Charges

₹34,850,000.00

Charges Breakdown by Lending Institutions
  • Panjab Financial Corporation : 1.25 Cr
  • State Bank Of India : 0.90 Cr
  • Sbi : 0.42 Cr
  • Panjab State Industrial Development Corpo Ltd : 0.39 Cr
  • Panjab Financial Corporantion : 0.30 Cr
  • Others : 0.24 Cr
Latest Charge Details
Date Lender Amount Status
20 Jan 1988 State Bnak Of India ₹1.45 M Satisfied
09 Jun 1987 Panjab Financial Corporantion ₹3.00 M Satisfied
12 Mar 1987 Panjab State Industrial Development Corpo Ltd ₹3.85 M Satisfied
02 Feb 1987 State Bank Of India ₹3.10 M Satisfied
26 Dec 1985 State Bank Of India ₹2.45 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Japson Pharmaceuticals (Pb)?

Unlock and access historical data on people associated with Japson Pharmaceuticals (Pb), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Japson Pharmaceuticals (Pb), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Japson Pharmaceuticals (Pb)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Japson Pharmaceuticals (Pb)
Recent Activity within the Organization
  • Annual General Meeting

    Japson Pharmaceuticals (Pb) Limited last Annual general meeting of members was held on 22 Jul 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Japson Pharmaceuticals (Pb) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    Pervesh Bir was appointed as a Director was appointed as a Director on 15 Jan 2024 & has been associated with this company since 2 years 1 month . was recorded as a recent event.

  • Director Appointment

    Progress on Angad Barnala Pratap was appointed as a Director was appointed as a Director on 03 May 2019 & has been associated with this company since 6 years 10 months . was documented.

  • Director Appointment

    Abhay Barnala was appointed as a Director was appointed as a Director on 03 May 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.

  • Charges

    The activity A charge registered on 09 Jun 1987 via Charge ID 90176446 with Panjab Financial Corporantion was fully satisfied on 12 Jun 2017. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Japson Pharmaceuticals (Pb) Limited?

The CIN of Japson Pharmaceuticals (Pb) Limited is U56102CH1983PLC005474.

Where is Japson Pharmaceuticals (Pb) Limited headquartered?

Japson Pharmaceuticals (Pb) Limited is headquartered at 6328, Ground Floor, Rajiv Vihar,, Manimajra, Chandigarh, 160101.

When was Japson Pharmaceuticals (Pb) Limited incorporated?

Japson Pharmaceuticals (Pb) Limited was incorporated on 16 June 1983.

Who are the current directors of Japson Pharmaceuticals (Pb) Limited?

The current directors of Japson Pharmaceuticals (Pb) Limited are

What is the primary industry of Japson Pharmaceuticals (Pb) Limited?

The primary industry of Japson Pharmaceuticals (Pb) Limited is Hospital And Medical Care.

Is Japson Pharmaceuticals (Pb) Limited a listed company?

Japson Pharmaceuticals (Pb) Limited is unlisted.

What is the capital structure of Japson Pharmaceuticals (Pb) Limited?

The authorized capital of Japson Pharmaceuticals (Pb) Limited is ₹8.00 M, and the paid-up capital is ₹6.50 M.

What is the compliance status of Japson Pharmaceuticals (Pb) Limited?

The compliance status of Japson Pharmaceuticals (Pb) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available